Mydriacyl (Tropicamide)

Tropicamide, the active ingredient in Mydriacyl, is an antimuscarinic presented as an ophthalmic solution for ocular use. It selectively relaxes the iris sphincter muscle, producing rapid pupil dilation and cycloplegia to aid diagnostic and therapeutic eye procedures in clinical settings and by ophthalmologists and other eye care professionals.

GNH USA supplies Mydriacyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance. Our distribution network ensures timely delivery to diverse healthcare settings.

Mydriacyl (tropicamide) is a mydriatic agent used in ophthalmology to achieve pupil dilation for various examinations and procedures.

Diagnostic eye examinations: provides rapid pupil dilation to facilitate fundus evaluation and retinal imaging. Pre‑operative ophthalmic procedures: induces cycloplegia to relax accommodation during intraocular surgery. Anterior segment imaging: enables clear visualization of the cornea and lens for slit‑lamp assessment.

Tropicamide may cause a range of ocular and systemic reactions, varying from mild to serious.

Common Side Effects: - Transient ocular burning or stinging: brief discomfort after instillation. - Blurred vision: temporary reduction in visual clarity. - Photophobia: heightened light sensitivity due to dilated pupil.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma: sudden pressure rise in susceptible individuals. - Allergic reaction: swelling, itching, or rash around the eye. - Systemic anticholinergic effects: dry mouth, rapid heart rate, or urinary retention.

When using Tropicamide, clinicians should observe several safety measures to minimize risks. - Assess intraocular pressure: evaluate for narrow‑angle glaucoma before administration. - Avoid in hypersensitivity: do not use if patient has known allergy to tropicamide or other antimuscarinics. - Use caution in children and the elderly: monitor for systemic absorption and prolonged effects. - Advise patients about visual disturbances: recommend avoiding driving or operating machinery until vision normalizes. - Store at room temperature: keep in original container, protect from light and moisture.

Tropicamide can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Systemic anticholinergics (e.g., atropine): additive anticholinergic effects may increase systemic toxicity. - Miotic agents (e.g., pilocarpine): antagonistic action reduces desired pupil dilation. - Other cycloplegic agents (e.g., cyclopentolate): combined use may cause prolonged cycloplegia.

Moderate Interactions (Monitor Closely): - Topical beta‑blockers: monitor intraocular pressure as dilation may affect pressure control. - Prostaglandin analogs: possible reduced efficacy in glaucoma management. - Systemic antihistamines: may enhance dryness and discomfort in the eye.